A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 495.78
C 33.02
GOOG 607.01
BAC 8.08
RIMM 15.58

Recently Added

CPIC 1.17
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.72

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.17
NBTH 12.50
IDVC 0.35
2.03 +0.00 (0.00%) SUPG

Click Here to Receive Instant E-mail and RSS Alerts


Trade SUPG now with

Stock Details

Last Trade:2.03 Change:+0.00 (0.00%) Prev Close:2.03 Open: 34.47 Days Range:2.03 – 2.03 52 Week Range: 1.99 - 3.35 Volume:19543 P/E: 7.52
EPS:0.27





Recent Blog Posts

Blog Posts on 09/15/11 at 7:17am
Tracking Joel Greenblatt's Magic Formula Portfolio
Blog Posts on 08/31/11 at 10:09am
Recent Changes To Joel Greenblatt's Magic Formula Portfolio
Blog Posts on 08/31/11 at 9:55am
SuperGen Acquiring Cel-Sci Would Be A Win-Win
Blog Posts on 08/23/11 at 6:32pm
18 Cheap Stocks With Falling P/E And Earnings On The Rise
Blog Posts on 07/18/11 at 10:58am
3 Biotech Stocks With Upcoming PDUFA Dates to Buy
Blog Posts on 07/15/11 at 6:54pm
5 Healthcare Stocks of Interest This Week
Blog Posts on 06/21/11 at 6:50am
Momentum Ideas: Top 21 Stocks Under $5 Undervalued by Enterprise Value
Blog Posts on 05/31/11 at 3:01pm
6 Prime Biotechs for Short and Long-Term Gains
Blog Posts on 05/31/11 at 2:46pm
2 Momentum Stocks and 1 ETF for Early Summer
Blog Posts on 05/09/11 at 8:07am
3 Late-Stage Leukemia Company Previews for ASCO 2011
Blog Posts on 04/27/11 at 8:20pm
SuperGen's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Blog Posts on 04/18/11 at 6:32am
Shareholders Question SuperGen's Planned Acquisition - And Growth Strategy
Blog Posts on 04/08/11 at 3:56pm
SuperGen: Merger Is A Step In The Right Direction
Blog Posts on 03/30/11 at 9:15am
Future Biotech Superstars
Blog Posts on 03/17/11 at 5:43am
SuperGen: Flush With Cash, But Drug Pipeline Is Anemic
Blog Posts on 02/28/11 at 8:20pm
SuperGen's CEO Discusses Q4 2010 Results - Earnings Call Transcript
Blog Posts on 12/21/10 at 7:11pm
Goodwill in Asset Value: Its Impact on 33 Stocks
Blog Posts on 11/14/10 at 4:24am
Novartis Pulls the Plug on Drug Trial: Biotech's Latest Mishaps
Blog Posts on 10/26/10 at 5:15am
SuperGen Q3 2010 Earnings Call Transcript
Blog Posts on 10/26/10 at 3:57am
Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer
Blog Posts on 09/07/10 at 6:47am
Investment Opportunities in AML Frontline Therapies
Blog Posts on 08/18/10 at 8:09am
Top 10 Stock Dividend Yields, Lowest Price-to-Sales and Price-to-Book Ratios
Blog Posts on 08/09/10 at 8:48am
Value Stock Screen Performance: August 2010
Blog Posts on 03/14/10 at 9:30am
Industry News Bytes: Delcath, Amylin and Access Pharma
Blog Posts on 12/14/09 at 3:48pm
Monday Options Recap
Blog Posts on 11/18/09 at 4:41pm
Biotech Stocks for a Possible Year-End Rally
Blog Posts on 11/01/09 at 3:26am
This Week in Biotech: More Treats than Tricks
Blog Posts on 10/27/09 at 5:53pm
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time
Blog Posts on 09/20/09 at 4:50pm
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Blog Posts on 09/11/09 at 5:49am
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up